Literature DB >> 27545490

Amyloid precursor protein processing and bioenergetics.

Heather M Wilkins1, Russell H Swerdlow2.   

Abstract

The processing of amyloid precursor protein (APP) to amyloid beta (Aβ) is of great interest to the Alzheimer's disease (AD) field. Decades of research define how APP is altered to form Aβ, and how Aβ generates oligomers, protofibrils, and fibrils. Numerous signaling pathways and changes in cell physiology are known to influence APP processing. Existing data additionally indicate a relationship exists between mitochondria, bioenergetics, and APP processing. Here, we review data that address whether mitochondrial function and bioenergetics modify APP processing and Aβ production.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha secretase; Alzheimer's disease; Amyloid beta; Amyloid precursor protein; BACE1; Bioenergetics; Gamma secretase; Mitochondria

Mesh:

Substances:

Year:  2016        PMID: 27545490      PMCID: PMC5316384          DOI: 10.1016/j.brainresbull.2016.08.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  130 in total

1.  The production of amyloid beta peptide is a critical requirement for the viability of central neurons.

Authors:  Leigh D Plant; John P Boyle; Ian F Smith; Chris Peers; Hugh A Pearson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

2.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 3.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

4.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

5.  Cell surface amyloid beta-protein precursor colocalizes with beta 1 integrins at substrate contact sites in neural cells.

Authors:  T Yamazaki; E H Koo; D J Selkoe
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

6.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

7.  Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

Authors:  Peizhong Mao; Maria Manczak; Marcus J Calkins; Quang Truong; Tejaswini P Reddy; Arubala P Reddy; Ulziibat Shirendeb; Herng-Hsiang Lo; Peter S Rabinovitch; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

8.  Glycolysis-respiration relationships in a neuroblastoma cell line.

Authors:  Russell H Swerdlow; Lezi E; Daniel Aires; Jianghua Lu
Journal:  Biochim Biophys Acta       Date:  2013-01-10

9.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

10.  beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.

Authors:  C Haass; A Y Hung; M G Schlossmacher; D B Teplow; D J Selkoe
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

View more
  56 in total

1.  Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.

Authors:  Agostino Palmeri; Roberta Ricciarelli; Walter Gulisano; Daniela Rivera; Claudia Rebosio; Elisa Calcagno; Maria Rosaria Tropea; Silvia Conti; Utpal Das; Subhojit Roy; Maria Adelaide Pronzato; Ottavio Arancio; Ernesto Fedele; Daniela Puzzo
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

Review 2.  Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.

Authors:  Sophia M Raefsky; Mark P Mattson
Journal:  Free Radic Biol Med       Date:  2016-11-29       Impact factor: 7.376

3.  Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Authors:  Tamas Fulop; Jacek M Witkowski; Anis Larbi; Abdelouahed Khalil; Georges Herbein; Eric H Frost
Journal:  J Neurovirol       Date:  2019-03-13       Impact factor: 2.643

Review 4.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 5.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

Review 6.  Ketogenic Diets for Adult Neurological Disorders.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

7.  [Correlation of cerebrospinal fluid amyloid β-protein 42 and neurofilament light protein levels with postoperative neurocognitive dysfunction in elderly patients].

Authors:  X Zhang; Q Fu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-04-20

Review 8.  Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target.

Authors:  Tauqeerunnisa Syeda; Jason R Cannon
Journal:  J Biochem Mol Toxicol       Date:  2021-01-04       Impact factor: 3.642

9.  CircRNA-ceRNA Network Revealing the Potential Regulatory Roles of CircRNA in Alzheimer's Disease Involved the cGMP-PKG Signal Pathway.

Authors:  Yuan Zhang; Lili Qian; Yingying Liu; Ying Liu; Wanpeng Yu; Yanfang Zhao
Journal:  Front Mol Neurosci       Date:  2021-05-21       Impact factor: 5.639

10.  Microbiome-Metabolomics Reveals Endogenous Alterations of Energy Metabolism by the Dushen Tang to Attenuate D-Galactose-Induced Memory Impairment in Rats.

Authors:  Jifeng Wang; Min He; Wenjun Guo; Yanhong Zhang; Xin Sui; Jianan Lin; Xiaoran Liu; Hui Li; Jing Li; Qing Yang; Mo Kan; Zhuang Zhang; Sitong Ming; Xiaobo Qu; Na Li
Journal:  Biomed Res Int       Date:  2021-05-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.